Literature DB >> 9806143

Hereditary insensitivity to pain with anhidrosis.

M Berkovitch1, L Copeliovitch, T Tauber, Z Vaknin, E Lahat.   

Abstract

Hereditary sensory neuropathy type IV is an autosomal-recessive disorder characterized by congenital insensitivity to pain and anhidrosis and resulting in recurrent hyperpyrexia, self-mutilation, recurrent infections, chronic osteomyelitis, bone and joint deformities, and limb amputations. Described is a child with signs as well as skin and nerve biopsy results compatible with this disease, emphasizing the importance of early diagnosis and appropriate medical and educational care to prevent complications.

Entities:  

Mesh:

Year:  1998        PMID: 9806143     DOI: 10.1016/s0887-8994(98)00047-2

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  5 in total

1.  Congenital insensitivity of pain with anhidrosis.

Authors:  Bhaskar Gupta
Journal:  Indian J Pediatr       Date:  2003-01       Impact factor: 1.967

2.  A case of congenital insensitivity to pain with anhidrosis.

Authors:  Ahmet Kağan Özkaya; Ekrem Güler; Elif Arık; Ali Rıza Namlı; Derya Cevizli; Olcay Güngör
Journal:  Turk Pediatri Ars       Date:  2014-06-01

Review 3.  Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism.

Authors:  Elyse M Cornett; Michelle A Carroll Turpin; Allison Pinner; Pankaj Thakur; Tamizh Selvan Gnana Sekaran; Harish Siddaiah; Jasmine Rivas; Anna Yates; G Jason Huang; Anitha Senthil; Narjeet Khurmi; Jenna L Miller; Cain W Stark; Richard D Urman; Alan David Kaye
Journal:  Curr Oncol Rep       Date:  2020-02-06       Impact factor: 5.075

4.  Cardiac arrest after anesthetic management in a patient with hereditary sensory autonomic neuropathy type IV.

Authors:  Yakup Ergül; Bariş Ekici; Sabiha Keskin
Journal:  Saudi J Anaesth       Date:  2011-01

5.  Arthritis in a child secondary to congenital insensitivity to pain and self-aggression. Why and when pain is good?

Authors:  Y Emad; A El Yasaki; Y Ragab; M Khalifa; O Moawayh; M Salama
Journal:  Clin Rheumatol       Date:  2006-06-13       Impact factor: 3.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.